Bone Marrow TransplantationTransplantation, HomologousBone MarrowGraft vs Host DiseaseBone Marrow CellsTissue DonorsLiver TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationKidney TransplantationTransplantation ConditioningLiving DonorsGraft SurvivalHistocompatibility TestingUnrelated DonorsHistocompatibilityWhole-Body IrradiationBone and BonesTransplantation ChimeraGraft RejectionAnemia, AplasticHematologic NeoplasmsLeukemiaTreatment OutcomeImmunosuppressive AgentsRecurrenceHeart TransplantationBusulfanTransplantation, IsogeneicDirected Tissue DonationTissue and Organ ProcurementBone Marrow PurgingHLA AntigensTime FactorsLung TransplantationStem Cell TransplantationSurvival AnalysisRetrospective StudiesHematopoietic Stem CellsCyclophosphamideSiblingsTransplantation ImmunologyCombined Modality TherapySurvival RateBone Marrow DiseasesOrgan TransplantationMice, Inbred C57BLHematopoiesisRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressionLeukemia, Myeloid, AcuteRemission InductionCadaverPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow ExaminationHepatic Veno-Occlusive DiseasePancreas TransplantationGraft vs Host ReactionAcute DiseaseLymphocyte DepletionLeukemia, MyeloidIslets of Langerhans TransplantationFollow-Up StudiesLymphoma, Non-HodgkinCell TransplantationBone RemodelingBone Marrow NeoplasmsLeukocyte TransfusionTransplantationAntineoplastic Combined Chemotherapy ProtocolsT-LymphocytesCyclosporineChimeraSevere Combined ImmunodeficiencyColony-Forming Units AssayMyelodysplastic SyndromesFlow CytometryCord Blood Stem Cell TransplantationActuarial AnalysisMice, Inbred BALB CCell DifferentiationHematologic DiseasesDisease-Free SurvivalTransplantation, HeterologousPrognosisLymphocyte TransfusionCell ProliferationBreast NeoplasmsTransplantation ToleranceBlood DonorsAntineoplastic AgentsCytomegalovirus InfectionsPeripheral Blood Stem Cell TransplantationGraft vs Tumor EffectNuclear FamilyCarmustineBone DensityNeoplasmsGraft vs Leukemia Effect